Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease
Fahimeh Sadat Gholam-Mostafaei, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Masoumeh Azimirad, Nasser Ebrahimi Daryani, Mohammad Reza Zali
Topics & Concepts
MedicineInfliximabMetronidazoleInflammatory bowel diseaseInternal medicineIncidence (geometry)Ulcerative colitisAntibioticsGastroenterologyDiseaseMicrobiologyOpticsBiologyPhysicsClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disordersHelicobacter pylori-related gastroenterology studies